Nadja Triller (Ljutomer, Slovenia), Charlotte Leduc (Strasbourg, France), Etienne Giroux Leprieur (Paris, France), Ilona Rousalova (Prague, Czech Republic)
Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Rainer G. Wiewrodt (Münster, Germany), Arik Bernard Schulze, Lars Henning Schmidt, Andreas Kuemmel, Lara Baie, Christoph Albers, Andreas Faldum, Dennis Görlich, Rainer Wiewrodt
|  |
MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma
Yasushi Horimasu (Hiroshima, Japan), Yasushi Horimasu, Nobuhisa Ishikawa, Sonosuke Tanaka, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Noboru Hattori, Hironobu Hamada, Nobuoki Kohno
| |
PIWI proteins as prognostic markers in non small cell lung cancer
Jorge Moisés Lafuente (Barcelona, Spain), Jorge Moisés, Alfons Navarro, Rut Tejero, Nuria Viñolas, Anna Cordeiro, Ramón M. Marrades, Dolors Fuster, Oriol Caritg, Carmen Muñoz, Laureano Molins, Josep Ramírez, Mariano Monzó
| |
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Florent Baty (St. Gallen, Switzerland), Florent Baty, Martin Brutsche
| |
Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Marina Petrovic (Kragujevac, Republic of Serbia), Marina Petrovic, Vladimir Jurišic, Ivan Cekerevac, Zorica Lazic, Gordana Kostic, Goran Davidovic
| |
Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development
Pablo Sanchez Salcedo (Orkoien (Navarra), Spain), Pablo Sanchez-Salcedo, Jessica Gonzalez, Diego Martinez-Urbistondo, Juan Berto, Pilar Rivera, Esmeralda Lopez-Zalduendo, Ana Belen Alcaide, Arantzazu Campo, Juan Pablo De Torres, Javier Zulueta
|  |
A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer
Lee Soyeon (Daegu, Republic of Korea), So Yeon Lee, Seung Soo Yoo, Mi Jung Hong, Hye Won Seo, Yong Dae Lee, Keum Ju Choi, Jin Eun Choi, Hyo Gyoung Kang, Yangki Seok, Eung Bae Lee, Kyung Min Shin, Ji Yun Jeong, Won Kee Lee, Shin Yup Lee, Jaehee Lee, Seung Ick Cha, Chang Ho Kim, Young Tae Kim, Sanghoon Jheon, Jae Yong Park
| |
p16(ink4) expression and spirometry tests have similar survival outcomes values in non-small-cell lung cancer patients
Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Rifat Sejdinovic, Edin Jusufovic, Dragan Keser, Besim Prnjavorac, Ljiljana Sejdinovic, Azra Okanovic
| |
The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer
Lars Schmidt (Münster, Germany), Lars Henning Schmidt, Andreas Kümmel, Dennis Görlich, Michael Mohr, Sebastian Bröckling, Inga Grünewald, Eva Wardelmann, Anne Schultheis, Jan-Henrik Mikesch, Benedikt Vietmeier, Carsten Müller-Tidow, Alessandro Marra, Christoph Schliemann, Wofgang E. Berdel, Wolfgang Hartmann, Wiewrodt Rainer
| |
Are serum leptin levels a prognostic factor in advanced lung cancer?
Ceyda Anar (Izmir, Turkey), Ceyda Anar, Derya Deniz, Serhat Erol, Yasemin Ozdogan, Melike Yuksel Yavuz, Ufuk Yilmaz, Huseyin Halilcolar
| |
Serum osteopontin as a prognostic marker in patients with lung cancer
Vasiliki Petta (Athens, Greece), Vasiliki Petta, Stelios Loukides, Konstantinos Kostikas, Georgios Papatheodorou, Kyriaki Cholidou, Yiannis Tomos, Spyridon Papiris, Nikolaos Koulouris, Petros Bakakos
| |
Does bronchial location of lung cancer influence overall survival?
Christophe Paris (Nancy, France), Christophe Paris, Patrice Avogbe, Jean-Michel Vignaud, Amandine Luc, Emmanuelle Penven, Isabelle Thaon
| |
Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI
Chia-yu Kuo (Tainan, Taiwan), Chia-Yu Kuo, Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, Jui-Ying Lee, Shah-Hwa Chou, Ta-Chih Liu, Ming-Shyan Huang, Inn-Wen Chong
| |
EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia
Suzana Mladinov (Split, Croatia), Suzana Mladinov, Ivan Skopljanac, Veljka Ivcevic, Sendi Kuret, Meri Glavina Durdov, Kornelija Miše
| |
The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma
Chung-Jen Huang (New Taipei city, Taiwan), Chung-Jen Huang, Wen-Hui Ku
| |
ALK/EML4 translocation in non-squamous NSCLC and their predictors
Margarida Dias (Vila Nova de Gaia, Portugal), Margarida Dias, Rita Linhas, Ana Antunes, Sérgio Campainha, Sara Conde, Ana Barroso
| |
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)?
Clotilde Fournier (Marseille, France), Clotilde Fournier de Lesquen, Laurent Greillier, Pascale Tomasini, Helene Barazzutti, Frederic Fina, Fabrice Barlesi
| |
Lung cancer patients harbouring epidermal growth factor receptor mutation
Catarina Carvalho de Oliveira Dias (Matosinhos, Portugal), Catarina Dias, David Araujo, Adriana Magalhaes, Henrique Queiroga, Venceslau Espanhol, Jose Machado, Conceiçao Moura, Agostinho Marques, Gabriela Fernandes
| |
RT-PCR expression of EML4-ALK oncogene in Bulgarian patients with non-small cell lung cancers
Dora Marinova (Sofia, Bulgaria), Dora Marinova, Darina Kachakova, Yanina Slavova, Gergana Stancheva, Atanaska Mitkova, Radka Kaneva, Dimitar Kostadinov, Vanyo Mitev
| |
Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
Shivalingaswamy Salimath (Davangere, India), Shivalingaswamy Salimath, B.S. Jayaraj, P.A. Mahesh
| |